Huons Global subsidiary Huons to merge with HuonsLab
휴온스글로벌
084110
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=634
Risk-adjusted indicator based on 634 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Merger Ratio (Huons:HuonsLab): 1 : 0.4256893
- • New Shares Issued: 3,825,327 Shares (24.20% of post-merger shares)
- • Huons Shareholder Buyback Price: 32,886 KRW
- • HuonsLab Asset Value: 808 KRW per share
- • HuonsLab Net Income (2025): -10.189B KRW
AI Analysis Summary
Huons, a subsidiary of Huons Global, will absorb HuonsLab to strengthen its R&D capabilities and new drug pipeline, aiming for global pharmaceutical growth. The merger ratio is 1:0.4256893, with Huons issuing 3,825,327 new shares (24.20% of post-merger shares). While R&D costs may increase short-term, the merger is expected to enhance financial structure, profitability, and sales through synergy, leveraging Huons' infrastructure and sales network. HuonsLab reported a net loss of 10.189B KRW in 2025. The deal includes a shareholder buyback option for Huons at 32,886 KRW per share. Overall, the merger is viewed positively for long-term value creation.
How This Event Is Evaluated
M&A / Merger Evaluation
M&A events are evaluated by assessing deal size relative to company scale, strategic rationale, financing structure, and integration risk.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Deal size relative to market value
- Strategic fit and synergy potential
- Financing structure (cash, stock, debt)
- Regulatory and integration risk
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.